Clinical Characterization of Autoimmune Hepatic Involvement in Sjogren’s Disease: A Retrospective Cohort Study in Korea
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125734 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Youngjae Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06…. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Hepatitis, Autoimmune. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Sjogren’s disease (SjD) is a systemic autoimmune disease primarily affecting the exocrine glands. Systemic manifestations, including hepatic involvement, are increasingly recognized. This study aimed to delineate the clinical features and associated factors of autoimmune hepatic involvement in SjD. A retrospective analysis was conducted on patients diagnosed with SjD at Seoul St. Mary’s Hospital over the past 10 years. Autoimmune hepatic involvement was defined by fulfilling diagnostic criteria for autoimmune hepatitis (AIH) or primary biliary cholangitis (PBC). Clinical, serological, and demographic data were obtained from medical records. Among 1119 patients with SjD, 51 (4.6%) had autoimmune hepatic involvement. AIH (64.7%) was the most common type, followed by PBC (27.5%) and overlapping disease (7.8%). Compared to those without hepatic involvement, affected patients were older at diagnosis (p = 0.003) and showed higher frequencies of thrombocytopenia, splenomegaly, anti-centromere antibody (ACA), and elevated antinuclear antibody titers as measured by indirect immunofluorescence (IFI-HEp-2) (all p < 0.001). Multivariable analysis identified splenomegaly, elevated IFI-HEp-2 titer, and ACA positivity as independent factors associated with hepatic involvement. Most patients responded well to immunosuppressive therapy, with only a small proportion (15.7%) progressing to liver fibrosis. Autoimmune hepatic involvement is relatively uncommon but clinically meaningful in patients with SjD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
ORCID-Profile: Youngjae Park, Ji Hyeon Ju, Wan-Uk Kim, Seung-Ki Kwok
Zitieren
APA
Park, Y., Lee, J. J., Ju, J. H., Kim, W. U., Park, S. H., & Kwok, S. K. (2025). Clinical Characterization of Autoimmune Hepatic Involvement in Sjogren’s Disease: A Retrospective Cohort Study in Korea. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125734
Vancouver
Park Y, Lee JJ, Ju JH, Kim WU, Park SH, Kwok SK. Clinical Characterization of Autoimmune Hepatic Involvement in Sjogren’s Disease: A Retrospective Cohort Study in Korea. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125734
BibTeX
@article{Park2025,
author = {Park, Youngjae and Lee, Jennifer Jooha and Ju, Ji Hyeon and Kim, Wan-Uk and Park, Sung-Hwan and Kwok, Seung-Ki},
title = {Clinical Characterization of Autoimmune Hepatic Involvement in Sjogren’s Disease: A Retrospective Cohort Study in Korea},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125734}
}
EUVIMED